In the case of miR-34a, a slightly increasing trend was observed for investigated patients compared to healthy subjects, but not statistically significant (Fig. 5 F).
← all excerpts
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential.
1
—
—